A Cost-Effectiveness Analysis of Biomarkers for Risk Prediction in Atrial Fibrillation

ConclusionPM compared to SOC is economically dominant and is projected to generate cost savings.
Source: Molecular Diagnosis and Therapy - Category: Molecular Biology Source Type: research